lavendustin a has been researched along with imatinib mesylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Arshad, H; Ashley, SW; Farivar, RS; Gardner-Thorpe, J; Ito, H; Whang, EE; Zinner, MJ | 1 |
| Alfonso, A; Botana, LM; Escribano, L; Löber, K | 1 |
3 other study(ies) available for lavendustin a and imatinib mesylate
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines.
Topics: Benzamides; Benzoquinones; Cell Division; Cell Line, Tumor; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genistein; Humans; Imatinib Mesylate; Lactams, Macrocyclic; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Phenols; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinones; Receptor, EphB3; Rifabutin | 2003 |
Influence of the tyrosine kinase inhibitors STI571 (Glivec), lavendustin A and genistein on human mast cell line (HMC-1(560)) activation.
Topics: Apoptosis; Benzamides; Calcium; Cell Line; Cell Proliferation; Enzyme Activation; Exocytosis; Genistein; Histamine Release; Humans; Imatinib Mesylate; Mast Cells; Phenols; Piperazines; Protein Kinase C; Protein-Tyrosine Kinases; Pyrimidines; Signal Transduction | 2008 |